{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:31:59Z","timestamp":1793215919544,"version":"4.5.0"},"reference-count":72,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2017,12,1]]},"DOI":"10.1001\/jamapsychiatry.2017.2943","type":"journal-article","created":{"date-parts":[[2017,10,19]],"date-time":"2017-10-19T18:31:31Z","timestamp":1508437891000},"page":"1206","source":"Crossref","is-referenced-by-count":204,"title":["A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia"],"prefix":"10.1001","volume":"74","author":[{"given":"Sameer","family":"Jauhar","sequence":"first","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College, London, England"},{"name":"Psychosis Clinical Academic Group, South London and Maudsley National Health Service Foundation Trust, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M.","family":"Nour","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College, London, England"},{"name":"Medical Research Council London Institute of Medical Sciences, Imperial College, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Veronese","sequence":"additional","affiliation":[{"name":"Centre for Neuroimaging Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rogdaki","sequence":"additional","affiliation":[{"name":"Medical Research Council London Institute of Medical Sciences, Imperial College, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Bonoldi","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College, London, England"},{"name":"Psychosis Clinical Academic Group, South London and Maudsley National Health Service Foundation Trust, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda","family":"Azis","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Turkheimer","sequence":"additional","affiliation":[{"name":"Centre for Neuroimaging Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"McGuire","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College, London, England"},{"name":"Psychosis Clinical Academic Group, South London and Maudsley National Health Service Foundation Trust, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan H.","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver D.","family":"Howes","sequence":"additional","affiliation":[{"name":"Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College, London, England"},{"name":"Psychosis Clinical Academic Group, South London and Maudsley National Health Service Foundation Trust, London, England"},{"name":"Medical Research Council London Institute of Medical Sciences, Imperial College, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"yoi170071r1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.64.1.19","article-title":"Lifetime prevalence of psychotic and bipolar I disorders in a general population.","volume":"64","author":"Per\u00e4l\u00e4","year":"2007","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"yoi170071r2","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","article-title":"Research domain criteria (RDoC): toward a new classification framework for research on mental disorders.","volume":"167","author":"Insel","year":"2010","journal-title":"Am J Psychiatry"},{"issue":"11","key":"yoi170071r3","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1176\/ajp.148.11.1474","article-title":"Dopamine in schizophrenia: a review and reconceptualization.","volume":"148","author":"Davis","year":"1991","journal-title":"Am J Psychiatry"},{"issue":"1","key":"yoi170071r4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.biopsych.2016.07.014","article-title":"The role of genes, stress, and dopamine in the development of schizophrenia.","volume":"81","author":"Howes","year":"2017","journal-title":"Biol Psychiatry"},{"issue":"3","key":"yoi170071r5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbp006","article-title":"The dopamine hypothesis of schizophrenia, version III: the final common pathway.","volume":"35","author":"Howes","year":"2009","journal-title":"Schizophr Bull"},{"issue":"3","key":"yoi170071r6","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/schbul\/sbq031","article-title":"Dopaminergic dysfunction in schizophrenia: salience attribution revisited.","volume":"36","author":"Heinz","year":"2010","journal-title":"Schizophr Bull"},{"issue":"8","key":"yoi170071r7","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nrn.2016.57","article-title":"Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression.","volume":"17","author":"Grace","year":"2016","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"yoi170071r8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00702-016-1561-2","article-title":"Dimensional psychiatry: mental disorders as dysfunctions of basic learning mechanisms.","volume":"123","author":"Heinz","year":"2016","journal-title":"J Neural Transm (Vienna)"},{"issue":"4","key":"yoi170071r9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1177\/026988119901300405","article-title":"Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies.","volume":"13","author":"Laruelle","year":"1999","journal-title":"J Psychopharmacol"},{"issue":"24","key":"yoi170071r10","doi-asserted-by":"crossref","first-page":"11651","DOI":"10.1073\/pnas.91.24.11651","article-title":"Elevated dopa decarboxylase activity in living brain of patients with psychosis.","volume":"91","author":"Reith","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"yoi170071r11","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment.","volume":"69","author":"Howes","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"yoi170071r12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biopsych.2012.11.017","article-title":"Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort.","volume":"74","author":"Egerton","year":"2013","journal-title":"Biol Psychiatry"},{"issue":"1","key":"yoi170071r13","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1001\/archgenpsychiatry.2008.514","article-title":"Elevated striatal dopamine function linked to prodromal signs of schizophrenia.","volume":"66","author":"Howes","year":"2009","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"yoi170071r14","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1176\/appi.ajp.2011.11010160","article-title":"Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study.","volume":"168","author":"Howes","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"9","key":"yoi170071r15","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/mp.2011.20","article-title":"Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study.","volume":"16","author":"Howes","year":"2011","journal-title":"Mol Psychiatry"},{"issue":"2","key":"yoi170071r16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.euroneuro.2012.04.015","article-title":"Striatal dopamine D2\/3 receptor binding following dopamine depletion in subjects at ultra high risk for psychosis.","volume":"23","author":"Bloemen","year":"2013","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"yoi170071r17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0920-9964(02)00167-6","article-title":"Psychosis prediction: 12-month follow up of a high-risk (\u201cprodromal\u201d) group.","volume":"60","author":"Yung","year":"2003","journal-title":"Schizophr Res"},{"issue":"5","key":"yoi170071r18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"yoi170071r20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.brat.2014.08.011","article-title":"Elevated reward-related neural activation as a unique biological marker of bipolar disorder: assessment and treatment implications.","volume":"62","author":"Nusslock","year":"2014","journal-title":"Behav Res Ther"},{"issue":"9","key":"yoi170071r21","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1038\/sj.npp.1301620","article-title":"Abnormal reward system activation in mania.","volume":"33","author":"Abler","year":"2008","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"yoi170071r22","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/archpsyc.1995.03950180057008","article-title":"In vivo D2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder.","volume":"52","author":"Pearlson","year":"1995","journal-title":"Arch Gen Psychiatry"},{"issue":"12","key":"yoi170071r23","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1176\/ajp.138.12.1624","article-title":"Induction of rapid mood cycling during L-dopa treatment in a bipolar patient.","volume":"138","author":"Ko","year":"1981","journal-title":"Am J Psychiatry"},{"issue":"2","key":"yoi170071r24","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1017\/S0033291700009132","article-title":"Dextroamphetamine-induced arousal in human subjects as a model for mania.","volume":"16","author":"Jacobs","year":"1986","journal-title":"Psychol Med"},{"key":"yoi170071r25","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1192\/bjp.179.4.356","article-title":"Antidopaminergic effects of dietary tyrosine depletion in healthy subjects and patients with manic illness.","volume":"179","author":"McTavish","year":"2001","journal-title":"Br J Psychiatry"},{"issue":"6","key":"yoi170071r26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/014107688708000620","article-title":"Psychiatric side effects of bromocriptine therapy for postpartum galactorrhoea.","volume":"80","author":"Kemperman","year":"1987","journal-title":"J R Soc Med"},{"key":"yoi170071r27","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1192\/bjp.182.3.210","article-title":"Effects of a branched-chain amino acid drink in mania.","volume":"182","author":"Scarna","year":"2003","journal-title":"Br J Psychiatry"},{"issue":"1","key":"yoi170071r28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jad.2013.08.041","article-title":"Dopamine depletion attenuates some behavioral abnormalities in a hyperdopaminergic mouse model of bipolar disorder.","volume":"155","author":"van Enkhuizen","year":"2014","journal-title":"J Affect Disord"},{"issue":"6","key":"yoi170071r29","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00004714-198512000-00006","article-title":"Induction of mania by L-dopa in a nonbipolar patient.","volume":"5","author":"Harsch","year":"1985","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"yoi170071r30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0163-8343(91)90041-T","article-title":"Mania precipitated by prednisone and bromocriptine.","volume":"13","author":"Fisher","year":"1991","journal-title":"Gen Hosp Psychiatry"},{"issue":"4","key":"yoi170071r31","first-page":"37","article-title":"Frequency of stimulant treatment and of stimulant-associated mania\/hypomania in bipolar disorder patients.","volume":"41","author":"Wingo","year":"2008","journal-title":"Psychopharmacol Bull"},{"issue":"11","key":"yoi170071r32","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/mp.2014.167","article-title":"Daytime spikes in dopaminergic activity drive rapid mood-cycling in mice.","volume":"20","author":"Sidor","year":"2015","journal-title":"Mol Psychiatry"},{"issue":"2","key":"yoi170071r33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0165-0327(83)90001-0","article-title":"Dopamine and mania: the effects of trans- and cis-clopenthixol in a double-blind pilot study.","volume":"5","author":"Nolen","year":"1983","journal-title":"J Affect Disord"},{"issue":"5","key":"yoi170071r34","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1176\/appi.ajp.159.5.768","article-title":"PET study of [18F]6-fluoro-l-dopa uptake in neuroleptic- and mood-stabilizer\u2013naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium.","volume":"159","author":"Yatham","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"2","key":"yoi170071r36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"issue":"5","key":"yoi170071r38","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity.","volume":"133","author":"Young","year":"1978","journal-title":"Br J Psychiatry"},{"issue":"3","key":"yoi170071r39","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/schbul\/sbv019","article-title":"The Optimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics.","volume":"41","author":"Leucht","year":"2015","journal-title":"Schizophr Bull"},{"issue":"10","key":"yoi170071r40","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1038\/npp.2014.87","article-title":"Dopamine function in cigarette smokers: an [18F]-DOPA PET study.","volume":"39","author":"Bloomfield","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"yoi170071r41","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/jcbfm.1993.85","article-title":"Pharmacokinetics of plasma 6-[18F]fluoro-l-3,4-dihydroxyphenylalanine ([18F]FDOPA) in humans.","volume":"13","author":"Cumming","year":"1993","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"yoi170071r42","doi-asserted-by":"crossref","first-page":"e1027","DOI":"10.1038\/tp.2016.270","article-title":"Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans.","volume":"7","author":"Jauhar","year":"2017","journal-title":"Transl Psychiatry"},{"issue":"3","key":"yoi170071r43","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/archgenpsychiatry.2010.10","article-title":"Increased synaptic dopamine function in associative regions of the striatum in schizophrenia.","volume":"67","author":"Kegeles","year":"2010","journal-title":"Arch Gen Psychiatry"},{"issue":"pt 11","key":"yoi170071r44","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1093\/brain\/awt264","article-title":"Midbrain dopamine function in schizophrenia and depression: a post-mortem and positron emission tomographic imaging study.","volume":"136","author":"Howes","year":"2013","journal-title":"Brain"},{"issue":"2","key":"yoi170071r46","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.neuroimage.2009.12.058","article-title":"The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function.","volume":"50","author":"Egerton","year":"2010","journal-title":"Neuroimage"},{"issue":"2","key":"yoi170071r47","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.neuroimage.2007.11.034","article-title":"Automatic segmentation of brain MRIs of 2-year-olds into 83 regions of interest.","volume":"40","author":"Gousias","year":"2008","journal-title":"Neuroimage"},{"issue":"3","key":"yoi170071r48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/01.WCB.0000048520.34839.1A","article-title":"Imaging human mesolimbic dopamine transmission with positron emission tomography, part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum.","volume":"23","author":"Martinez","year":"2003","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"yoi170071r49","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1177\/1073858409338217","article-title":"PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches.","volume":"15","author":"Kumakura","year":"2009","journal-title":"Neuroscientist"},{"issue":"5","key":"yoi170071r52","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mp.2017.16","article-title":"The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment.","volume":"22","author":"Ashok","year":"2017","journal-title":"Mol Psychiatry"},{"issue":"8","key":"yoi170071r53","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1399-5618.2009.00760.x","article-title":"The role of dopamine in bipolar disorder.","volume":"11","author":"Cousins","year":"2009","journal-title":"Bipolar Disord"},{"issue":"1","key":"yoi170071r54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0920-9964(98)00113-3","article-title":"Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia.","volume":"35","author":"Hietala","year":"1999","journal-title":"Schizophr Res"},{"issue":"2-3","key":"yoi170071r55","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.schres.2008.09.011","article-title":"Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging.","volume":"106","author":"Bose","year":"2008","journal-title":"Schizophr Res"},{"issue":"5","key":"yoi170071r56","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0006-3223(99)00109-2","article-title":"Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(\u00df-11C) DOPA and PET.","volume":"46","author":"Lindstr\u00f6m","year":"1999","journal-title":"Biol Psychiatry"},{"issue":"3","key":"yoi170071r57","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nn804","article-title":"Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia.","volume":"5","author":"Meyer-Lindenberg","year":"2002","journal-title":"Nat Neurosci"},{"issue":"1","key":"yoi170071r58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0925-4927(00)00064-0","article-title":"6-18F-DOPA PET study in patients with schizophrenia.","volume":"100","author":"Elkashef","year":"2000","journal-title":"Psychiatry Res"},{"issue":"4","key":"yoi170071r59","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4088\/JCP.08m04227","article-title":"McLean-Harvard International First-Episode Project: two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients.","volume":"70","author":"Salvatore","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"yoi170071r60","first-page":"1936","article-title":"Correction of head movement on PET studies: comparison of methods.","volume":"47","author":"Montgomery","year":"2006","journal-title":"J Nucl Med"},{"issue":"16","key":"yoi170071r61","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/0024-3205(78)90471-X","article-title":"Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity.","volume":"23","author":"Bunney","year":"1978","journal-title":"Life Sci"},{"issue":"2","key":"yoi170071r62","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/syn.1071","article-title":"Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo.","volume":"41","author":"Danielsen","year":"2001","journal-title":"Synapse"},{"issue":"1","key":"yoi170071r63","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0166-2236(96)10064-3","article-title":"Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs.","volume":"20","author":"Grace","year":"1997","journal-title":"Trends Neurosci"},{"issue":"4","key":"yoi170071r64","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/sj.npp.1300103","article-title":"Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo.","volume":"28","author":"Gr\u00fcnder","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"yoi170071r66","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/00004647-200104000-00015","article-title":"A reversible tracer analysis approach to the study of effective dopamine turnover.","volume":"21","author":"Sossi","year":"2001","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"yoi170071r67","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/jcbfm.1985.87","article-title":"Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data: generalizations.","volume":"5","author":"Patlak","year":"1985","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"yoi170071r68","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01250373","article-title":"Brain kinetics of L-[\u00df-11C]DOPA in humans studied by positron emission tomography.","volume":"86","author":"Hartvig","year":"1991","journal-title":"J Neural Transm Gen Sect"},{"issue":"7","key":"yoi170071r69","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1176\/appi.ajp.157.7.1108","article-title":"Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients.","volume":"157","author":"Anand","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"9799","key":"yoi170071r70","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0140-6736(11)60873-8","article-title":"Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis.","volume":"378","author":"Cipriani","year":"2011","journal-title":"Lancet"},{"issue":"9896","key":"yoi170071r71","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis.","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"issue":"5","key":"yoi170071r72","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.biopsych.2013.06.011","article-title":"Antipsychotic treatment resistance in schizophrenia associated with elevated glutamate levels but normal dopamine function.","volume":"75","author":"Demjaha","year":"2014","journal-title":"Biol Psychiatry"},{"key":"yoi170071r19","volume-title":"Manic-Depressive Illness: Bipolar Disorders and Recurrent Depression","author":"Goodwin","year":"2007"},{"key":"yoi170071r35","volume-title":"Structured Clinical Interview for DSM-IV Axis II Personality Disorders, (SCID-II)","author":"First","year":"1997"},{"key":"yoi170071r37","doi-asserted-by":"crossref","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","DOI":"10.1176\/appi.books.9780890425596"},{"key":"yoi170071r50"},{"key":"yoi170071r51","year":"2009"},{"key":"yoi170071r65","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9780511575853","volume-title":"Imaging Dopamine","author":"Cumming","year":"2009"},{"key":"yoi170071r45","unstructured":"SPM. Statistical parametric mapping. http:\/\/www.fil.ion.ucl.ac.uk\/spm\/. Accessed October 5, 2016."}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamapsychiatry\/article-pdf\/74\/12\/1206\/17684887\/jamapsychiatry_jauhar_2017_oi_170071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T11:03:45Z","timestamp":1561547025000},"score":1,"resource":{"primary":{"URL":"http:\/\/archpsyc.jamanetwork.com\/article.aspx?doi=10.1001\/jamapsychiatry.2017.2943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,1]]},"references-count":72,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.2943","relation":{},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12,1]]}}}